1 day Hims Claws Back After Its Lilly-Rivaling Obesity Plan Faces An Unexpected Hitch Investor's Business Daily
Hims stock clawed higher Wednesday though analysts laid out low expectations for Him & Hers’ branded tirzepatide.
The post Hims Claws Back After Its Lilly-Rivaling Obesity Plan Faces An Unexpected Hitch appeared first on Investor's Business D…